You can:
Name | Beta-2 adrenergic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADRB2 |
Synonym | beta-2 adrenergic receptor Gpcr7 beta2-adrenoceptor Adrb-2 ADRB2R [ Show all ] |
Disease | Premature labour Premature ejaculation Obesity Neurogenic bladder dysfunction Hypertension [ Show all ] |
Length | 413 |
Amino acid sequence | MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL |
UniProt | P07550 |
Protein Data Bank | 3nya, 3ny9, 3ny8, 3d4s, 2rh1, 3pds, 4gbr, 4lde, 6mxt, 6csy, 5x7d, 5jqh, 5d6l, 5d5b, 5d5a, 4ldo, 4ldl, 4qkx |
GPCR-HGmod model | P07550 |
3D structure model | This structure is from PDB ID 3nya. |
BioLiP | BL0257082, BL0113951, BL0113950, BL0257084, BL0257085, BL0283869, BL0333729, BL0333730, BL0333731,BL0333732,BL0333733, BL0333734, BL0333735, BL0333736,BL0333737,BL0333738, BL0113952,BL0113953,BL0113954, BL0147310, BL0257081, BL0257080, BL0232997, BL0192129, BL0257083, BL0185746,BL0185747, BL0185745, BL0185743,BL0185744, BL0185742, BL0185740,BL0185741, BL0147311,BL0147312, BL0351701,BL0351703, BL0351702,BL0351704, BL0192128, BL0433200, BL0433199, BL0430930, BL0430929, BL0388810, BL0388809, BL0354449, BL0185748, BL0354450, BL0354451,BL0354452,BL0354453, BL0388807,BL0388808 |
Therapeutic Target Database | T24555, T52522 |
ChEMBL | CHEMBL210 |
IUPHAR | 29 |
DrugBank | BE0000694 |
Name | UNII-P50A5YTO0O |
---|---|
Molecular formula | C31H27F3N4O3S2 |
IUPAC name | N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzenesulfonamide |
Molecular weight | 624.697 |
Hydrogen bond acceptor | 11 |
Hydrogen bond donor | 3 |
XlogP | 5.3 |
Synonyms | CHEMBL111201 SCHEMBL1276546 (R)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzenesulfonamide Benzenesulfonamide, N-(4-(2-(((2R)-2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)-2-thiazolyl)- [ Show all ] |
Inchi Key | MSOUIIHPMJCUNI-LJAQVGFWSA-N |
Inchi ID | InChI=1S/C31H27F3N4O3S2/c32-31(33,34)25-9-5-22(6-10-25)28-20-42-30(37-28)23-7-13-27(14-8-23)43(40,41)38-26-11-3-21(4-12-26)15-17-36-19-29(39)24-2-1-16-35-18-24/h1-14,16,18,20,29,36,38-39H,15,17,19H2/t29-/m0/s1 |
PubChem CID | 3038500 |
ChEMBL | CHEMBL111201 |
IUPHAR | N/A |
BindingDB | 50092645 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
ACT | 25.0 % | PMID11052788 | ChEMBL |
EC50 | 2400.0 nM | PMID11052788 | BindingDB,ChEMBL |
IA | 1.0 - | PMID15149682 | ChEMBL |
IC50 | 670.0 nM | PMID26709102 | BindingDB,ChEMBL |
IC50 | 2300.0 nM | PMID11052788, PMID20181479 | BindingDB,ChEMBL |
Intrinsic activity | 1.0 % | PMID17632003 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417